Why the study?
The physiological signal for DevS has remained unclear, with conflicting reports on whether it functions as a redox or an oxygen sensor.
The study validates that the DevS protein in Mycobacterium tuberculosis functions as an oxygen sensor directly involved in dormancy/latency, rather than a redox sensor.
Tuberculosis is one of the oldest known infectious diseases, responsible for millions of deaths annually around the world. The ability of Mycobacterium tuberculosis (Mtb) to enter into a dormant state has been considered integral to the success of this bacterium as a human pathogen. One of the key systems involved in regulating the entrance into dormancy is the differentially expressed in virulent strain sensor protein (DevS) [(dormancy survival sensor protein (DosS)]. However, the physiological signal for DevS has remained unclear since it was first shown to be a heme‐based sensor with conflicting reports on whether it is a redox or an oxygen sensor. To address this question and provide a better understanding of the electronic properties of this protein, we present here, for the first time, a series of spectroelectrochemistry measurements of the full‐length holo DevS in anaerobic conditions as well as bound to CO, NO, imidazole (Imz), cyanide, and O 2 . An interesting feature of this protein is its ability to bind Imz even in the ferrous state, implying small‐molecule analogues could be designed as potential regulators. Nonetheless, a midpoint potential ( E m ) value of +10 mV [vs normal hydrogen electrode (NHE)] for DevS as measured under anaerobic conditions is much higher than the expected cytosolic potential for Mtb or even within stimulated macrophages (~ −270 mV vs NHE), indicating this sensor works in a reduced ferrous state. These data, along with the high oxygen affinity and very slow auto‐oxidation rate of DevS, provides evidence that it is not a redox sensor. Overall, this study validates the biological function of DevS as an oxygen sensor directly involved in the dormancy/latency of Mtb.
No takes yet. Share an insight, caveat, or question.
Barreto et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: